ATX 12.0% 8.8¢ amplia therapeutics limited

Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer, page-22

  1. 315 Posts.
    lightbulb Created with Sketch. 37
    What you state is not clear from the announcement.
    But assuming all have had preliminary scans who needs confirmatory ones and why?
    When will they be done?
    Unclear how this fits into best practice by the existing protocols.
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.